Navigation Links
Blizzard, McCarthy & Nabers Launches ReglanJustice.com
Date:3/9/2010

Informs Public of Serious Risks Associated with Use of Reglan and Metoclopramide: Provides Solutions for Legal Recourse

HOUSTON, March 9 /PRNewswire-USNewswire/ -- Blizzard, McCarthy & Nabers, one of the nation's leading pharmaceutical litigation firms is proud to announce the launch of ReglanJustice.com, an educational website aimed at informing consumers of the risks associated with the use of the drug Reglan, and its generic form, metoclopramide.  As a resource for the millions of Americans who use this drug, ReglanJustice.com is regularly updated with the latest news and medical information surrounding the medication and its causal link to debilitative movement disorders.

Long-term use of Reglan and generic forms of metoclopramide has been linked to Tardive Dyskinesia, a serious involuntary and repetitive movement disorder that is often irreversible. A recent study cited by the FDA, reports the prevalence of Tardive Dyskinesia at 20 percent among patients treated with Reglan for at least 12 weeks. In February 2009, the FDA issued a Black Box warning against continued use of Reglan to treat gastrointestinal disorders.

ReglanJustice.com is meant to provide consumers with the critical information denied to them by the pharmaceutical manufacturers marketing these drugs.  For those consumers who have already been disabled by these products, ReglanJustice.com provides an avenue to seek legal redress.  Corporations that operate with an eye on the bottom line rather than the safety of their consumers must be held accountable for their actions.  For more information, visit www.reglanjustice.com.

"As attorneys, we've seen first hand the damage that can be done by these powerful and dangerous drugs," said Scott Nabers, partner at Blizzard, McCarthy & Nabers.  "Consumers were misinformed about the risks associated with this product and many have been permanently disabled.  It is our hope that this website will provide consumers with critical information so that future patients can avoid these troubling side effects."

In January, the firm launched www.denturecreamjustice.com to provide information and avenues to legal recourse for consumers poisoned by zinc in denture cream.

Blizzard, McCarthy & Nabers, LLP, one of the nation's leading pharmaceutical litigation firms, represents thousands of clients harmed by dangerous drugs and medical devices and has taken on some of the world's largest corporations, including Bristol-Myers, GlaxoSmithKline, Merck, Pfizer and Dow Chemical. 

SOURCE Blizzard, McCarthy & Nabers, LLP

Back to top

RELATED LINKS
http://reglanjustice.com/

'/>"/>

SOURCE Blizzard, McCarthy & Nabers, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification
2. Neurocrine Biosciences to Present at the 30th Annual Cowen & Co. Health Care Conference
3. P&M Corporate Finance and Robin Young Announce 2010 Spine Technology Summit
4. 2nd Annual Orthopedic Design & Technology Forum Returns April 28 to the FedEx Institute of Technology, University of Memphis
5. TransMedics, Inc. Secures $36 Million Round of Financing Lead by Foundation Capital and Kleiner Perkins Caufield & Byers
6. UBM Announces Plans for Japan Pharma & Bio Events
7. Frost & Sullivan Recognizes Timoptic(R) (timolol maleate) as Best Brand Name Beta Blocker for Glaucoma: Timoptic Brand is Highest Rated in Survey of Ophthalmologists
8. Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review
9. China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Aurora Womens Pavilion Center for Sexual Health & Wellness Receives Grant to Treat Vulvar Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Feb. 22, 2017 Summary Provides ... partnering deals and agreements entered into by the worlds ... http://www.reportlinker.com/p03605668-summary/view-report.html Description The Global Non-Small Cell Lung ... understanding and access to partnering deals and agreements entered ... - Trends in partnering deals - Top deals ...
(Date:2/22/2017)... , February 22, 2017 Arthroscopy Devices Market Report, published ... in 2015 and is projected to reach $5,334 million by 2022, growing at a ... of the total market in 2015. Continue Reading ... ... ...
(Date:2/22/2017)... MERIDEN, Conn. , Feb. 22, 2017   ... and maker of Flublok® Influenza Vaccine , announced ... The Partnership for Influenza Vaccine Introduction (PIVI) and the ... the devastating impacts of the flu.  The doses of ... of Mongolia for health care ...
Breaking Medicine Technology:
(Date:2/22/2017)... IL (PRWEB) , ... February 22, 2017 , ... South ... is proud to once again feature Heroes On The Water (HOW), a non-profit organization ... season’s all new episode has series host ‘Mike D’ traveling to Lake Denmark, New ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... chronic conditions reported skipping doses or not filling a prescription because they could ... rates of cost-related problems getting medications were 30-60%*. At the same ...
(Date:2/22/2017)... ... 2017 , ... Sideline Products participated in the World Horse Expo held in ... and his production crew. Tom Seay’s program “Best of America by Horseback” is ... Sidekicks will be featured on April 6, 2017. After the broadcast, the clip will ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... country today, as organizations, advocates, and individuals join together to increase recognition about ... to ultimately save lives. , “Today we mark a nationwide movement to raise ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s ... spine practices, is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon ... small number of neurosurgeons in Michigan performing minimally invasive back surgery that often ...
Breaking Medicine News(10 mins):